Rachel received her bachelor's degree in biology and psychology at Mount Saint Mary's University in May 2017. Prior joining the Rando lab in April 2022, she studied changes in the gut microbiome of patients post breast cancer radiation therapies and understanding the role of antifungals and PD-1/PDL1 therapies in murine breast cancer models with Dr. Stephen Shiao, Dr. Jose Limon-Tello and Dr. Kathleen Kershaw at Cedar Sinai Medical Center's department of radiation oncology. Following that position, she led clinical manufacturing campaigns with Dr. Sheyla Gonzalez and Dr. Maxime Ruiz at the UCLA Jules Stein Ophthalmology Department culturing the limbal stem cell transplantational drug product. 

At the Rando Lab, she handles all lab operations.